Edal, Rey L.
HRN: 29-21-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
MUPIROCIN 2%, 15G (TUBE)
06/22/2026
06/29/2026
TOPICAL
AS NEEDED
BID
T/c Sepsis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines